• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高频率截断和长检测间期植入式心律转复除颤器程控在二级预防患者中的安全性和有效性

Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.

作者信息

Hayashi Yusuke, Takagi Masahiko, Kakihara Jun, Sakamoto Shogo, Doi Atsushi, Sugioka Kenichi, Hanatani Akihisa, Yoshiyama Minoru

机构信息

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.

出版信息

Heart Vessels. 2017 Feb;32(2):175-185. doi: 10.1007/s00380-016-0850-x. Epub 2016 Jun 3.

DOI:10.1007/s00380-016-0850-x
PMID:27259484
Abstract

Several trials demonstrated that a long detection interval and a high-rate cutoff reduced implantable cardioverter-defibrillator (ICD) therapy in primary prevention patients. However, only a few data are available for secondary prevention (SP) patients. The aim of this study was to evaluate whether these ICD programming would be effective in reducing ICD therapies in SP patients. We enrolled 65 SP patients under ICD or cardiac resynchronization therapy with the defibrillator programmed with the same setting (conventional setting). During follow-up, we changed detection rates in each zone; cycle length (CL) ≤400 to ≤370 ms for ventricular tachycardia (VT) zone, CL ≤350 to ≤320 ms for fast VT zone, CL ≤300 to ≤270 ms for ventricular fibrillation (VF) zone, and number of intervals to detect ventricular tachyarrhythmia in VF zone: 12-24. We retrospectively compared the incidences of ICD therapies, syncope, and hospitalization due to slow VT under the detection rate between both settings. Median follow-up periods were 5.0 (interquartile range 2.5-7.8) and 2.5 years (interquartile range 2.3-2.7) in conventional and strategic settings, respectively. The incidence of appropriate ATP and shock significantly decreased in strategic setting (conventional and strategic settings: 21.2 and 4.8 ATPs per year, respectively, OR 0.18, 95 % CI 0.06-0.54, p = 0.002, 26.1 and 7.8 shocks per year, respectively, OR 0.29, 95 % CI 0.09-0.88, p = 0.03). The incidence of overall inappropriate therapy significantly decreased (conventional and strategic settings: 17.6 and 2.8 therapies per year, respectively, OR 0.14, 95 % CI 0.05-0.44, p = 0.01). The incidence of syncope and slow VT was not significantly different between both settings. In conclusion, ICD programming-combined long detection interval with high-rate cutoff was effective in reducing appropriate shock and inappropriate therapy without increasing the incidence of syncope and slow VT in SP patients.

摘要

多项试验表明,较长的检测间期和较高的心率截断值可减少一级预防患者的植入式心律转复除颤器(ICD)治疗。然而,关于二级预防(SP)患者的数据却很少。本研究的目的是评估这些ICD程控设置在减少SP患者的ICD治疗方面是否有效。我们纳入了65例接受ICD或心脏再同步治疗加除颤器的SP患者,其除颤器设置为相同的常规设置。在随访期间,我们改变了每个区域的检测率;室性心动过速(VT)区域的周长(CL)从≤400毫秒改为≤370毫秒,快速VT区域的CL从≤350毫秒改为≤320毫秒,心室颤动(VF)区域的CL从≤300毫秒改为≤270毫秒,VF区域检测室性快速心律失常的间期数量从12 - 24个。我们回顾性比较了两种设置下检测率对应的ICD治疗、晕厥和因缓慢VT住院的发生率。常规设置和策略性设置的中位随访期分别为5.0年(四分位间距2.5 - 7.8年)和2.5年(四分位间距2.3 - 2.7年)。在策略性设置下,恰当的抗心动过速起搏(ATP)和电击发生率显著降低(常规设置和策略性设置:每年分别为21.2次和4.8次ATP,OR 0.18,95%CI 0.06 - 0.54,p = 0.002;每年分别为26.1次和7.8次电击,OR 0.29,95%CI 0.09 - 0.88,p = 0.03)。总体不恰当治疗的发生率显著降低(常规设置和策略性设置:每年分别为17.6次和2.8次治疗,OR 0.14,95%CI 0.05 - 0.44,p = 0.01)。两种设置下晕厥和缓慢VT的发生率无显著差异。总之,ICD程控设置——长检测间期与高心率截断值相结合,在不增加SP患者晕厥和缓慢VT发生率的情况下,有效减少了恰当电击和不恰当治疗。

相似文献

1
Safety and efficacy of high-rate cutoff and long detection interval ICD programming in secondary prevention patients.高频率截断和长检测间期植入式心律转复除颤器程控在二级预防患者中的安全性和有效性
Heart Vessels. 2017 Feb;32(2):175-185. doi: 10.1007/s00380-016-0850-x. Epub 2016 Jun 3.
2
Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.在一级预防患者人群中,采用策略性植入式心脏复律除颤器程控以降低电击治疗负担的安全性和有效性。
Europace. 2014 Feb;16(2):227-34. doi: 10.1093/europace/eut302. Epub 2013 Oct 9.
3
Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.长检测间期埋藏式心脏转复除颤器设置在二级预防人群中的疗效:来自植入式心脏转复除颤器患者避免治疗非持续心律失常 III 期临床试验(ADVANCE III)的数据。
Circulation. 2014 Jul 22;130(4):308-14. doi: 10.1161/CIRCULATIONAHA.114.009468. Epub 2014 May 16.
4
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.植入式心脏复律除颤器检测与治疗参数的策略性编程可减少一级预防患者的电击次数:PREPARE(一级预防参数评估)研究结果
J Am Coll Cardiol. 2008 Aug 12;52(7):541-50. doi: 10.1016/j.jacc.2008.05.011.
5
Results of ENHANCED Implantable Cardioverter Defibrillator Programming to Reduce Therapies and Improve Quality of Life (from the ENHANCED-ICD Study).增强型植入式心脏复律除颤器编程以减少治疗并改善生活质量的结果(来自增强型植入式心脏复律除颤器研究)
Am J Cardiol. 2016 Feb 15;117(4):596-604. doi: 10.1016/j.amjcard.2015.11.052. Epub 2015 Dec 7.
6
Long Detection Programming in Single-Chamber Defibrillators Reduces Unnecessary Therapies and Mortality: The ADVANCE III Trial.单腔除颤器中的长检测编程可减少不必要的治疗和死亡率:ADVANCE III 试验。
JACC Clin Electrophysiol. 2017 Nov;3(11):1275-1282. doi: 10.1016/j.jacep.2017.05.001. Epub 2017 May 31.
7
Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.二级预防性植入式心脏复律除颤器适应症患者中适当的植入式心脏复律除颤器治疗的发生率及预测因素
Europace. 2016 Feb;18(2):227-31. doi: 10.1093/europace/euv188. Epub 2015 Jun 10.
8
Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.长检测间隔与标准检测间隔对植入式心脏复律除颤器抗心动过速起搏和电击治疗效果的影响:ADVANCE III 随机临床试验。
JAMA. 2013 May 8;309(18):1903-11. doi: 10.1001/jama.2013.4598.
9
Reprogramming the tachycardia parameters with long-detection strategy in patients with pre-existing implantable cardioverter-defibrillator.在已植入植入式心脏复律除颤器的患者中采用长检测策略重新编程心动过速参数。
Acta Cardiol. 2019 Jun;74(3):246-251. doi: 10.1080/00015385.2018.1488664. Epub 2018 Jul 28.
10
Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial.将植入式心律转复除颤器治疗区域程控至较高范围以预防一级预防患者不适当的设备治疗:RISSY-ICD(通过增加区域减少不适当电击)试验结果
Am J Cardiol. 2015 May 1;115(9):1235-43. doi: 10.1016/j.amjcard.2015.01.558. Epub 2015 Feb 12.

引用本文的文献

1
Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions.植入式心脏复律除颤器心动过速治疗:过去、现在与未来方向
J Cardiovasc Dev Dis. 2024 Mar 20;11(3):92. doi: 10.3390/jcdd11030092.
2
Safety and Efficacy of an Implantable Cardioverter Defibrillator (ICD) in the Detection and Prevention of Cardiac Arrhythmia - A Systematic Review.植入式心脏复律除颤器(ICD)在检测和预防心律失常中的安全性和有效性——一项系统评价
Cureus. 2023 Nov 7;15(11):e48471. doi: 10.7759/cureus.48471. eCollection 2023 Nov.
3
Inappropriate ICD Shocks in Pediatric and Congenital Heart Disease Patients.

本文引用的文献

1
Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: a systematic review and a meta-analysis of randomized controlled trials.缺血性心脏病患者室性心动过速(VT)的导管消融:一项随机对照试验的系统评价和荟萃分析。
J Interv Card Electrophysiol. 2016 Mar;45(2):111-7. doi: 10.1007/s10840-015-0083-4. Epub 2015 Dec 22.
2
Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation.非缺血性心肌病患者在植入心脏复律除颤器前预防性导管消融室性心动过速:单次心内膜消融后的临床结果
J Arrhythm. 2015 Jun;31(3):122-9. doi: 10.1016/j.joa.2014.09.007. Epub 2015 Feb 4.
3
小儿及先天性心脏病患者不适当的植入式心律转复除颤器电击
J Innov Card Rhythm Manag. 2017 Nov 15;8(11):2898-2906. doi: 10.19102/icrm.2017.081104. eCollection 2017 Nov.
4
Surface electromyography of myopotential oversensing provoked by simultaneous straining and leftward twisting in a patient with an implantable cardioverter defibrillator.一名植入式心脏复律除颤器患者在同时用力和向左扭转时引发肌电位过度感知的表面肌电图。
Heart Vessels. 2017 Mar;32(3):364-368. doi: 10.1007/s00380-016-0888-9. Epub 2016 Aug 30.
Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation.与心外膜双极标测图相比,心内膜单极标测图中较大的低电压区表明通过导管消融消除室性心动过速存在困难。
Heart Vessels. 2016 Aug;31(8):1337-46. doi: 10.1007/s00380-015-0732-7. Epub 2015 Aug 13.
4
Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis.按心率范围对首次及后续不适当植入式心律转复除颤器治疗进行特征描述及预测因素分析:MADIT-RIT疗效分析结果
Heart Rhythm. 2015 Sep;12(9):2030-7. doi: 10.1016/j.hrthm.2015.05.021. Epub 2015 May 19.
5
Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.与单腔治疗相比,双腔治疗可降低植入式心律转复除颤器不适当电击的风险:随机 OPTION 研究结果。
JACC Heart Fail. 2014 Dec;2(6):611-9. doi: 10.1016/j.jchf.2014.05.015. Epub 2014 Oct 1.
6
Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).多中心自动除颤器植入试验-降低不适当治疗(MADIT-RIT)中与植入式心脏复律除颤器编程相关的死亡率。
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):785-92. doi: 10.1161/CIRCEP.114.001623. Epub 2014 Aug 18.
7
Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.长检测间期埋藏式心脏转复除颤器设置在二级预防人群中的疗效:来自植入式心脏转复除颤器患者避免治疗非持续心律失常 III 期临床试验(ADVANCE III)的数据。
Circulation. 2014 Jul 22;130(4):308-14. doi: 10.1161/CIRCULATIONAHA.114.009468. Epub 2014 May 16.
8
Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.旨在减少不必要的植入式心脏复律除颤器治疗的编程策略对死亡率的影响:系统评价和荟萃分析。
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):164-70. doi: 10.1161/CIRCEP.113.001217. Epub 2014 Jan 20.
9
Suppression of ventricular fibrillation by electrical modification of the Purkinje system in hypertrophic cardiomyopathy.肥厚型心肌病中通过对浦肯野系统进行电改造来抑制心室颤动
Heart Vessels. 2014 Sep;29(5):709-17. doi: 10.1007/s00380-013-0423-1. Epub 2013 Oct 11.
10
Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study.在具有一级预防指征的患者中编程植入式心律转复除颤器以延长首次电击时间:来自 PROVIDE 研究的结果。
J Cardiovasc Electrophysiol. 2014 Jan;25(1):52-9. doi: 10.1111/jce.12273. Epub 2013 Sep 24.